Don't let the six weeks of market rallies trick you. There are still ways to get in on blue-chip companies at pre-rally prices. Closed-end funds continue to trade at sharp discounts to their actual holdings.
Shares of Tri-Continental
Tri-Continental, for example, closed at $8.60 a share yesterday. If it was a more conventional open-end mutual fund, it would be trading at its actual NAV of $10.13 a share.
Closed-end funds have been neglected by the media over the years. They never had the marketing arms of their open-end funds. They are bought and sold on stock exchanges throughout the day, but the somewhat similar exchange-traded funds (ETFs) are the ones winning over investors.
This doesn't mean that you should follow the herd and dismiss these closed-end vehicles. Let's take a look at Tri-Continental's largest holdings.
Johnson & Johnson
If these sound like names that you can picture in your own portfolio, buying in through a company trading for 85 cents on the dollar probably sounds attractive. What's the catch? Well, it's not as if Tri-Continental is gouging its shareowners. It has a modest annual expense ratio of 0.68%. It also doesn't have a lot of built-in tax liabilities to pass on to its investors, as its smacked-down portfolio began the year with a net unrealized capital loss of $3.90 a share (so an investor can expect dividends, but no capital gains distributions in the near term).
Still looking for the catch? Well, there is a big one. The stock has historically traded at a similar discount. So buying in at a 15% discount sounds great, but you may also have to sell at a roughly 15% discount on the way out, unless the company converts to an open-end fund.
However, I'm a big fan of closed-end funds for a few reasons:
- Most stock funds trade at a discount to NAV.
- Because they have fixed asset bases, they don't have to manage for inflows or outflows of capital.
- Trading perpetually gives investors an easier way to time their purchases and eventual sales.
So keep an eye on closed-end funds, because somebody has to.
Other ways to get down with the bargains:
If you want to find deals with conventional open-end mutual funds, check out Champion Funds. Pfizer and Wal-Mart Stores are Motley Fool Inside Value recommendations. Johnson & Johnson is a Motley Fool Income Investor pick. Try any of our Foolish newsletters today, free for 30 days.
Longtime Fool contributor Rick Munarriz feels that not every bargain is a bargain, but he's willing to give it a shot. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. He does not own shares in any of the companies in this story. The Fool has a disclosure policy.